[Previous] Live Poultry is sold despite Avian Flu breakout...

 [Next] Philip Morris, Canadian firm team up for avian flu vaccine...

Some related posts from Technorati and Google.

 [Drug Industry Daily] Novartis Says Experimental Vaccine Protects Against Avian Flu: investigational bird flu vaccine Aflunov generated a rapid immune response in individuals who had received a separate vaccine as much as six years earlier, according to the company.

 [Bird Flus and how it relates to me] Sanofi to give 60 million doses of bird flu vaccine to WHO ”¦: WHO has been encouraged by scientific advisers to put together a stockpile of 150 million doses of H5N1 vaccine. Fifty million doses would be used to try to contain a pandemic at source, while the remaining 100 million doses would be shared among countries which otherwise would not have access to pandemic vaccine so they could protect some key workers.

[Medicine, drugs and health] UK Shop Meat Checked For Bird Flu Virus: Tests have shown that the avian flu which killed 2600 turkeys at a Suffok farm is the H5N1 virus. Food Standards Agency advice, that avian flu does not pose a food safety risk for UK consumers, remains unchanged.

 [On Target] A Pandemic That Wasn’t but Might Be: McNeil Jr., The New York Times - Last year, for the first time since avian flu emerged as a global threat, the number of human cases was down from the year before. As the illness receded, the scary headlines ”” with their warnings of a pandemic that could kill 150 million people ”” all but vanished.

 [QDIS Blog] Vaccine May Treat Many Bird Flu Strains: Other companies such as Novartis and Sanofi-Aventis has also seen cross-protection in their vaccines. What is interesting is the GSK is using a proprietary adjunct which can increase the number of doses by 10-fold.

[Avian Flu Current] Avian bird flu influenza: Sanofi-Aventis SA, Novartis AG and GlaxoSmithKline Plc won US contracts totaling almost $200 million to add 5.3 million doses of flu vaccine to a government stockpile in preparation for a pandemic. The vaccine is intended to protect .

[Avian Tamiflu] Biocryst Jumps on FDA OK: ”¦ Tamiflu Approved for Children. Novartis Won’t Raise Chiron Bid ”¦ Despite timely treatment with Tamiflu, an avian flu strain resistant to the drug could .

 [VentureBeat] A biotech flu vaccine and the seduction of hype: The background: Flu vaccines are traditionally time-consuming and laborious to produce, since the most widely-used vaccine consists mostly of proteins harvested from inactivated flu virus, requiring mass quantities of virus. Until recently, the most reliable way to culture the virus was to grow it in vast collections of sterile chicken eggs, a 60-year-old process that takes about six months from start to finish.

 [Dandelion Salad] Unleashing GMO Seeds: “Food is Power” by Stephen Lendman: Engdahl covered pertinent information on the industry that might otherwise have gone unnoticed - that the three US GMO giants have a long sordid association with the Pentagon supplying massively destructive chemicals like Agent Orange, napalm and others. They now want to be trusted with the most important things we ingest - our food and drugs in the face of strong evidence their GMO varieties harm human health and their history of public safety concern is atrocious.

[flu symptoms] NHS Direct - Health encyclopaedia -Flu (Flu symptoms): false 7F11BA9A98C5DD7D4887ADF tag:http://www.the-information-society.com/flu-symptoms/2007/01/flu-symptoms-avian-flu-influenza-symptoms-of-bird-flu-what-is-bird-flu.php,2006:blog-1169415492 ...

 [theurbanhermit] theurbanhermit @ 2006-12-15T09:40:00: The company hasn't yet settled on a location, but said the new office will house 250 executives and researchers for Novartis Vaccines and Diagnostics , a unit that makes flu shots and blood tests. Their arrival next year will bring Novartis's total Cambridge footprint to nearly a million square feet and 1,550 people, larger than local biotechnology giants Genzyme Corp.

 [Patience is a Virtue] After Decades of Malaise, the Vaccine Industry Is Getting an Injection: According to Danzon's vaccine study, Wyeth produced influenza vaccine for the U.S. market for more than 20 years, but in October 2000 the company was fined $30 million for manufacturing violations and an additional $15,000 for every day that it remained out of compliance. In November 2002, Wyeth announced it would exit the flu market, leaving only two manufacturers of injectable influenza vaccine.

Reflected tags on Technorati: Blog, "avian Flu", Bird Flu Monitor